Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases

• Main Authors: Vishakha Singh (Author), Amit Khurana (Author), Prince Allawadhi (Author), Anil Kumar Banothu (Author), Kala Kumar Bharani (Author), Ralf Weiskirchen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Programmed cell death protein 1 (PD-1)/PD-ligand (L)1, the immune checkpoint inhibitors have emerged as a promising strategy for the treatment of various diseases including chronic liver diseases (CLDs) such as hepatitis, liver injury and hepatocellular carcinoma (HCC). The role of PD-1/PD-L1 has be...